E. Jaźwińska-Tarnawska

Genetic polymorphism of ABCB1 gene (C3435T) in patients with inflammatory bowel diseases. Is there any gender dependency?

E. Waszczuk, A. Mulak, L. Paradowski, 2015, Pharmacological reports : PR.

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

W. E. Sanabria, John A. Hamling, Ju Han Kim, 2019, The Lancet.

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.

W. E. Sanabria, John A. Hamling, Ju Han Kim, 2019, Lancet.

Application of Novel Pharmacists’ Risk in Pharmacotherapy (PHARIPH) Scale for Identification of Factors Affecting the Safety of Hospital Pharmacotherapy—An Observational Pilot Study

E. Jaźwińska-Tarnawska, A. Wiela-Hojeńska, I. Witczak, 2022, International journal of environmental research and public health.

Determinants of disease acceptance in renal transplantation patients assessed with the application of Acceptance Illness Scale (AIS).

M. Krajewska, E. Jaźwińska-Tarnawska, A. Wiela-Hojeńska, 2021, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

Quality of Life in Patients with Advanced Non-Small-Cell Lung Cancer Receiving Palliative Chemotherapy.

E. Jaźwińska-Tarnawska, A. Brzecka, A. Dryś, 2019, Advances in experimental medicine and biology.

The influence of CYP2D6 polymorphism on the antiarrhythmic efficacy of propafenone in patients with paroxysmal atrial fibrillation during 3 months propafenone prophylactic treatment.

E. Jaźwińska-Tarnawska, K. Loboz-grudzień, J. Sławin, 2001, International journal of clinical pharmacology and therapeutics.

The influence of locally implanted high doses of gentamicin on hearing and renal function of newborns treated for acute hematogenous osteomyelitis.

E. Jaźwińska-Tarnawska, M. Kos, W. Pilecki, 2003, International journal of clinical pharmacology and therapeutics.

C3435T Polymorphism of the ABCB1 Gene in Polish Patients with Inflammatory Bowel Disease: A Case–Control and Meta-Analysis Study

E. Poniewierka, E. Jaźwińska-Tarnawska, K. Głowacka, 2021, Genes.

CYP2D6 extensive, intermediate, and poor phenotypes and genotypes in a Polish population

E. Jaźwińska-Tarnawska, Z. Forkasiewicz, P. Niewinski, 2002, European Journal of Clinical Pharmacology.

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.

W. E. Sanabria, John A. Hamling, Ju Han Kim, 2019, Lancet.

Genetic polymorphism of ABCB1 gene (C3435T) in patients with inflammatory bowel diseases. Is there any gender dependency?

E. Waszczuk, A. Mulak, L. Paradowski, 2015, Pharmacological reports : PR.